Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities
Sinha, R., Edmonds, K., Newton-Bishop, J.A., Gore, M.E., Larkin, J., Fearfield, L.
Published in British journal of dermatology (1951) (01.11.2012)
Published in British journal of dermatology (1951) (01.11.2012)
Get full text
Journal Article
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
MOTZER, R. J, ESCUDIER, B, BUKOWSKI, R, RINI, B. I, HUTSON, T. E, BARRIOS, C. H, LIN, X, FLY, K, MATCZAK, E, GORE, M. E
Published in British journal of cancer (25.06.2013)
Published in British journal of cancer (25.06.2013)
Get full text
Journal Article
A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology
DE LESO, P. B, COWARD, J. I, LETSA, I, SCHICK, U, NANDHABALAN, M, FRENTZAS, S, GORE, M. E
Published in British journal of cancer (29.10.2013)
Published in British journal of cancer (29.10.2013)
Get full text
Journal Article
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
GLASSPOOL, R. M, BROWN, R, GABRA, H, HALFORD, S. E. R, WALKER, J, APPLETON, K, ULLAH, R, KAYE, S, GORE, M. E, RUSTIN, G. J. S, McNEISH, I. A, WILSON, R. H, PLEDGE, S, PAUL, J, MACKEAN, M, HALL, G. D
Published in British journal of cancer (15.04.2014)
Published in British journal of cancer (15.04.2014)
Get full text
Journal Article
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
HUTSON, T. E, BUKOWSKI, R. M, MARTELL, B, MATCZAK, E, MOTZER, R. J, RINI, B. I, GORE, M. E, LARKIN, J. M, FIGLIN, R. A, BARRIOS, C. H, ESCUDIER, B, LIN, X, FLY, K
Published in British journal of cancer (04.03.2014)
Published in British journal of cancer (04.03.2014)
Get full text
Journal Article
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
O'DAY, S, PAVLICK, A, MOHR, P, OTTENSMEIER, C, CHAO, D, ZHONG, B, DE BOER, C. J, UHLAR, C, MARSHAILL, D, GORE, M. E, LANG, Z, HAIT, W, LOQUAI, C, HO, P, LAWSON, D, GUTZMER, R, RICHARDS, J, SCHADENDORF, D, THOMPSON, J. A, GONZALEZ, R, TREFZER, U
Published in British journal of cancer (26.07.2011)
Published in British journal of cancer (26.07.2011)
Get full text
Journal Article
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer
EISEN, T, BOSHOFF, C, MAK, I, SAPUNAR, F, VAUGHAN, M. M, PYLE, L, JOHNSTON, S. R. D, AHERN, R, SMITH, I. E, GORE, M. E
Published in British journal of cancer (01.02.2000)
Published in British journal of cancer (01.02.2000)
Get full text
Journal Article
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens
KRASNER, C. N, MCMEEKIN, D. S, CHAN, S, BRALY, P. S, RENSHAW, F. G, KAYE, S, PROVENCHER, D. M, CAMPOS, S, GORE, M. E
Published in British journal of cancer (17.12.2007)
Published in British journal of cancer (17.12.2007)
Get full text
Journal Article
U.K. guidelines for the management of cutaneous melanoma
Roberts, D.L.L., Anstey, A.V., Barlow, R.J., Cox, N.H., Bishop, J.A. Newton, Corrie, P.G., Evans, J., Gore, M.E., Hall, P.N., Kirkham, N.
Published in British journal of dermatology (1951) (01.01.2002)
Published in British journal of dermatology (1951) (01.01.2002)
Get full text
Journal Article
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
GORDON, Alan N, FLEAGLE, John T, GUTHRIE, David, PARKIN, David E, GORE, Martin E, LACAVE, Angel J
Published in Journal of clinical oncology (15.07.2001)
Published in Journal of clinical oncology (15.07.2001)
Get full text
Journal Article
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies
EISEN, T, MARAIS, R, JOUARY, T, HARRIES, M, NEGRIER, S, MONTEGRIFFO, E, AHMAD, T, GIBBENS, I, JAMES, M. G, STRAUSS, U. P, PRENDERGAST, S, GORE, M. E, AFFOLTER, A, LORIGAN, P, ROBERT, C, CORRIE, P, OTTENSMEIER, C, CHEVREAU, C, CHAO, D, NATHAN, P. D
Published in British journal of cancer (26.07.2011)
Published in British journal of cancer (26.07.2011)
Get full text
Journal Article
A phase I II trial of sorafenib and infliximab in advanced renal cell carcinoma
LARKIN, Jmg, FERGUSON, T. R, PICKERING, L. M, EDMONDS, K, JAMES, M. G, THOMAS, K, BANERJI, U, BERNS, B, DE BOER, C, GORE, M. E
Published in British journal of cancer (12.10.2010)
Published in British journal of cancer (12.10.2010)
Get full text
Journal Article
Temsirolimus in the treatment of advanced renal cell carcinoma
Get full text
Journal Article
Conference Proceeding
Mucinous ovarian cancer
Harrison, M L, Jameson, C, Gore, M E
Published in International journal of gynecological cancer (01.03.2008)
Published in International journal of gynecological cancer (01.03.2008)
Get full text
Journal Article
Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)
Gore, M.E, Bellmunt, J, Eisen, T, Escudier, B, Mickisch, G, Patard, J, Porta, C, Ravaud, A, Schmidinger, M, Schöffski, P, Sternberg, C.N, Szczylik, C, Lewis, S, Kirpekar, S
Published in European journal of cancer (1990) (01.12.2014)
Published in European journal of cancer (1990) (01.12.2014)
Get full text
Journal Article
Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology
Gore, M.E, Bellmunt, J, Eisen, T, Escudier, B, Mickisch, G, Patard, J, Porta, C, Ravaud, A, Schmidinger, M, Schöffski, P, Sternberg, C.N, Szczylik, C, De Nigris, E, Wheeler, C, Kirpekar, S
Published in European journal of cancer (1990) (01.05.2012)
Published in European journal of cancer (1990) (01.05.2012)
Get full text
Journal Article
Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer
Bishara, S, Griffin, M, Cargill, A, Bali, A, Gore, M.E, Kaye, S.B, Shepherd, J.H, Van Trappen, P.O
Published in European journal of obstetrics & gynecology and reproductive biology (01.05.2008)
Published in European journal of obstetrics & gynecology and reproductive biology (01.05.2008)
Get full text
Journal Article
Second primary melanomas on treatment with vemurafenib: reply from the authors
Fearfield, L., Newton-Bishop, J.A., Sinha, R., Edmonds, K., Gore, M.E., Larkin, J.
Published in British journal of dermatology (1951) (01.04.2013)
Published in British journal of dermatology (1951) (01.04.2013)
Get full text
Journal Article
Significance of tumour calcification in ovarian carcinoma
BURKILL, G. J. C, ALLEN, S. D, A'HERN, R. P, GORE, M. E, KING, D. M
Published in British journal of radiology (01.08.2009)
Published in British journal of radiology (01.08.2009)
Get full text
Journal Article